Breast Cancer, Version 4.2021 Featured Updates to the NCCN Guidelines
Breast Cancer, Version 4.2021 Featured Updates to the NCCN Guidelines
复制标题
DOI：
10.6004/jnccn.2021.0023
复制
发表时间：
2021-05-01
影响因子：
13.4
通讯作者：
Kumar, Rashmi
中科院分区：
文献类型：
--
作者：
Gradishar, William J.;Moran, Meena S.;Kumar, Rashmi
NCCN乳腺癌指南包括原位癌、浸润性乳腺癌、佩吉特病、叶状肿瘤、炎性乳腺癌、男性乳腺癌和妊娠期乳腺癌患者临床管理的最新指南。这些指南是由NCCN成员机构的代表组成的多学科小组制定的，这些机构在医学肿瘤学、外科肿瘤学、放射肿瘤学、病理学、重建手术和患者宣传领域具有以乳腺癌为重点的专业知识。这些NCCN指南见解关注非转移性、早期、激素受体阳性、HER2阴性乳腺癌患者辅助全身治疗建议的最新更新。
The NCCN Guidelines for Breast Cancer include up-to-date guidelines for clinical management of patients with carcinoma in situ, invasive breast cancer, Paget disease, phyllodes tumor, inflammatory breast cancer, male breast cancer, and breast cancer during pregnancy. These guidelines are developed by a multidisciplinary panel of representatives from NCCN Member Institutions with breast cancer-focused expertise in the fields of medical oncology, surgical oncology, radiation oncology, pathology, reconstructive surgery, and patient advocacy. These NCCN Guidelines Insights focus on the most recent updates to recommendations for adjuvant systemic therapy in patients with nonmetastatic, early-stage, hormone receptor-positive, HER2-negative breast cancer.